🔗 Share this article Patients Discontinuing Weight-Loss Medications Regain Weight Four Times Faster Than Dieters Weight management often requires ongoing approaches. Fresh analysis indicates that patients who stop using new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans. Published data in a major medical journal shows that while obese individuals can lose a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping. "People buying such drugs must be informed of the danger of fast weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb. Such speed of regain means a reversion to pre-treatment mass within about one and a half years. Analyzing Treatments The research, which looked at 37 of studies involving thousands of patients, contrasted the results of these new drugs with other pills. The team emphasize that people who shed pounds through lifestyle changes alone typically see a more gradual creep back—perhaps 100 grams monthly—post-intervention. Explaining the Quick Regain Experts propose the way of the jabs explains the heightened rebound. These medications mimic a natural hormone called GLP-1, which controls hunger. "Long-term administration of the hormone levels far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher. "Discontinuation of this medication results in appetite is unsuppressed, making binge eating a significant risk." A Chronic Disease? Medical guidelines suggest the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications. Many experts say that, due to the likelihood of weight regain, the treatment might need to be life-long. This opinion is echoed by drug manufacturers, who state that the results "underscore the chronic character of excess weight," akin to managing diseases like diabetes. Patient Testimonies People who have come off the jabs describe a intense return of appetite. "I experienced a switch that goes on and you're instantly extremely hungry," described a patient. This difficulty is exacerbated if individuals have not established permanent dietary or behavioural modifications during treatment. Widespread Interest Figures indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial. Adoption is more common among females compared to men. The middle-aged age group shows the greatest level of interest. A large proportion access the medications through private prescriptions rather than public health services. Finally, researchers caution that while the jabs are effective agents for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle support.
Weight management often requires ongoing approaches. Fresh analysis indicates that patients who stop using new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans. Published data in a major medical journal shows that while obese individuals can lose a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping. "People buying such drugs must be informed of the danger of fast weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb. Such speed of regain means a reversion to pre-treatment mass within about one and a half years. Analyzing Treatments The research, which looked at 37 of studies involving thousands of patients, contrasted the results of these new drugs with other pills. The team emphasize that people who shed pounds through lifestyle changes alone typically see a more gradual creep back—perhaps 100 grams monthly—post-intervention. Explaining the Quick Regain Experts propose the way of the jabs explains the heightened rebound. These medications mimic a natural hormone called GLP-1, which controls hunger. "Long-term administration of the hormone levels far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher. "Discontinuation of this medication results in appetite is unsuppressed, making binge eating a significant risk." A Chronic Disease? Medical guidelines suggest the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications. Many experts say that, due to the likelihood of weight regain, the treatment might need to be life-long. This opinion is echoed by drug manufacturers, who state that the results "underscore the chronic character of excess weight," akin to managing diseases like diabetes. Patient Testimonies People who have come off the jabs describe a intense return of appetite. "I experienced a switch that goes on and you're instantly extremely hungry," described a patient. This difficulty is exacerbated if individuals have not established permanent dietary or behavioural modifications during treatment. Widespread Interest Figures indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial. Adoption is more common among females compared to men. The middle-aged age group shows the greatest level of interest. A large proportion access the medications through private prescriptions rather than public health services. Finally, researchers caution that while the jabs are effective agents for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle support.